Drug abuse involves the pharmacologic activation of neural pathways involved in reward. Dopamine mediates these pathways and drugs of abuse bypass the normal stimuli for reward by increasing dopamine release more directly. This non-physiological activation then produces changes in synaptic transmission that presumably underlie tolerance, physical dependence and drug craving. Drug abuse therefore provides a model for neural plasticity in the reward pathway that has clear relevance for behavior. Amphetamines induce the release of dopamine stores from synaptic vesicles into the cytoplasm and from the cytoplasm into the synapse. Studies of the mechanism indicate a role for monoamine transporters. Consistent with this, Dr. Sulzer has recently shown that amphetamine reduces quantal size. Interestingly, amphetamine also reduces the frequency of release and FD2 dopamine receptor stimulation alone produces similar changes, suggesting that regulation of transmitter release may have a normal role in the reward pathway and other neural systems. Changes in quantal size and frequency of release may also contribute to drug addiction. Recent developments now enable us to identify the presynaptic mechanisms that regulate transmitter release. Dr. Sulzer will use direct, voltammetric measurement of dopamine in both PC12 cells and primary neuronal; cultures to characterize the effect of D2 receptor activation on dopamine release. To identify the molecular mechanisms responsible for changes in quantal size, Dr. Edwards has isolated cDNA clones encoding the vesicular monoamine transporters and will characterize their potential to reverse (and its role in amphetamine action), their regulation by phosphorylation and their intracellular trafficking. Recent developments in understanding regulated exocytosis, endocytosis and the biogenesis of synaptic vesicles enable Dr. Kelly to determine the role of the synaptic vesicle cycle in regulating transmitter release. Dr. Sulzer will then use voltammetry and primary neuronal cultures to determine the significance of these biochemical mechanisms for dopamine release. In summary, this program will allow three investigators with complementary expertise to explore the role of recently identified molecular mechanisms in synaptic transmission and neural plasticity. The focus on dopamine provides an important new context to address these general issues, one that has central importance for the reward pathway and drug abuse.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Program Projects (P01)
Project #
5P01DA010154-05
Application #
2898007
Study Section
Special Emphasis Panel (SRCD (02))
Program Officer
Rutter, Joni
Project Start
1995-09-30
Project End
2000-08-31
Budget Start
1999-09-20
Budget End
2000-08-31
Support Year
5
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of California San Francisco
Department
Neurology
Type
Schools of Medicine
DUNS #
073133571
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Henke, Adam; Kovalyova, Yekaterina; Dunn, Matthew et al. (2018) Toward Serotonin Fluorescent False Neurotransmitters: Development of Fluorescent Dual Serotonin and Vesicular Monoamine Transporter Substrates for Visualizing Serotonin Neurons. ACS Chem Neurosci 9:925-934
Dunn, Matthew; Boltaev, Umed; Beskow, Anne et al. (2018) Identification of Fluorescent Small Molecule Compounds for Synaptic Labeling by Image-Based, High-Content Screening. ACS Chem Neurosci 9:673-683
Borgkvist, Anders; Lieberman, Ori J; Sulzer, David (2018) Synaptic plasticity may underlie l-DOPA induced dyskinesia. Curr Opin Neurobiol 48:71-78
Liang, Samantha I; van Lengerich, Bettina; Eichel, Kelsie et al. (2018) Phosphorylated EGFR Dimers Are Not Sufficient to Activate Ras. Cell Rep 22:2593-2600
Clark, Samuel D; Mikofsky, Rachel; Lawson, Jacqueline et al. (2018) Piezo High Accuracy Surgical Osteal Removal (PHASOR): A Technique for Improved Cranial Window Surgery in Mice. J Vis Exp :
Siljee, Jacqueline E; Wang, Yi; Bernard, Adelaide A et al. (2018) Subcellular localization of MC4R with ADCY3 at neuronal primary cilia underlies a common pathway for genetic predisposition to obesity. Nat Genet 50:180-185
Eichel, Kelsie; JulliƩ, Damien; Barsi-Rhyne, Benjamin et al. (2018) Catalytic activation of ?-arrestin by GPCRs. Nature 557:381-386
Dunn, Matthew; Henke, Adam; Clark, Samuel et al. (2018) Designing a norepinephrine optical tracer for imaging individual noradrenergic synapses and their activity in vivo. Nat Commun 9:2838
Fischer, Kathryn D; Houston, Alex C W; Desai, Rajeev I et al. (2018) Behavioral phenotyping and dopamine dynamics in mice with conditional deletion of the glutamate transporter GLT-1 in neurons: resistance to the acute locomotor effects of amphetamine. Psychopharmacology (Berl) 235:1371-1387
Eichel, Kelsie; von Zastrow, Mark (2018) Subcellular Organization of GPCR Signaling. Trends Pharmacol Sci 39:200-208

Showing the most recent 10 out of 128 publications